MedTrace Logo

Prediction of Fetal Macrosomia by US

NCT03451838 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2019-01-09

No results posted yet for this study

Summary

Fetal macrosomia defined as birth weight above 90th centile ,macrosomia occurs in 42-62%of pregnancy complicated by type 1 diabetes mellitus ,in 30-56% of pregnancy complicated by type 2 diabetes mellitus .

-The delivery of macrosomic infant has potentially severe consequence for both the newborn and mother .Increased birth weight increase the risk in the fetus of shoulder dystocia and premature brachial plexus injury ,and those infant weighing above 4500g are at increased risk for neonatal morbidity ,including the need for assisted ventilation and meconium aspiration .Maternal complication result from operative delivery and include postpartum hemorrhage ,third or fourth degree laceration and postpartum infection .

Conditions

  • Fetal Macrosomia

Interventions

DIAGNOSTIC_TEST

Ultrasound

Ultrasound will be done to every pregnant lady

DIAGNOSTIC_TEST

HbA1c level in blood

a blood sample will be taken to measure HbA1c level

Sponsors & Collaborators

  • Kasr El Aini Hospital

    collaborator OTHER

  • National Research Centre, Egypt

    collaborator OTHER

  • Aljazeera Hospital

    lead OTHER

Principal Investigators

  • Mahmoud Alalfy, M.s.c · Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

  • Ahmed samy, M.D · kasraliny hospital- Aljazeerah hospital

Eligibility

Min Age
18 Years
Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-03
Primary Completion
2019-05-05
Completion
2019-06-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03451838 on ClinicalTrials.gov